Gazyva 1000mg Solution for Infusion
Marketer
Roche Products India Pvt Ltd
Salt Composition
Obinutuzumab (1000mg)
Overview Gazyva 1000mg Solution for Infusion
Obinutuzumab 1000mg intravenous solution treats chronic lymphocytic leukemia (CLL), a type of blood cancer. Its mechanism involves binding to cancer cell receptors, marking them for elimination by the body's immune system. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may adjust over time. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include inflammation of the nose and throat (nasopharyngitis), upper respiratory infections, skin rashes, influenza-like symptoms, dermatitis, and eczema. Report any persistent or bothersome side effects to your physician. Regular blood tests monitor blood cell counts and vital organ (heart, liver, kidney) function. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent medications, especially those for infections, before commencing treatment. Numerous drug interactions are possible; disclose all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding. Effective contraception for both partners is crucial throughout treatment to prevent pregnancy. A patient support/assistance program exists in India, facilitated by Tata 1mg. Consult your doctor or call 1800-102-1618 for program details.
Uses of Gazyva 1000mg Solution for Infusion
Managing Chronic Lymphocytic Leukemia
Major Benefits of Gazyva 1000mg Solution for Infusion:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Gazyva 1000mg Solution for Infusion:
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
- Rash
- Flu
- Dermatitis
- Bronchitis (inflammation of the airways)
- Eczema
- Swelling of lymph nodes
- Oropharyngeal pain
How to use Gazyva 1000mg Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gazyva 1000mg Solution for Infusion works:
Obinutuzumab 1000mg intravenous solution targets and binds to CD20 proteins found on both leukemic and certain normal blood cells. This binding triggers either direct leukemia cell destruction or facilitates their elimination by the body's immune defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while using Gazyva 1000mg Infusion Solution is undetermined. Seek medical advice from your physician.
PregnancyCONSULT YOUR DOCTOR
The use of Gazyva 1000mg Infusion Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gazyva 1000mg Infusion Solution while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Gazyva 1000mg Infusion Solution on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Obinutuzumab 1000mg intravenous solution requires careful administration in individuals with impaired renal function. Dosage modification of Obinutuzumab 1000mg intravenous solution may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Obinutuzumab 1000mg solution for infusion can be administered to patients with hepatic impairment without dosage modification. Nevertheless, close monitoring of HBV-positive individuals is crucial throughout and following therapy; treatment with obinutuzumab 1000mg solution for infusion should be ceased if HBV reactivation occurs.
What if you forget to take Gazyva 1000mg Solution for Infusion :
NA
Facts to Know About Gazyva 1000mg Solution for Infusion
| Label | Value |
|---|---|
| Chemical Category | Short chains of amino acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Monoclonal antibody therapy |
3,018 People bought this recently